Genometrix CEO Robert Ellis Appointed Affymetrix Product Development and Quality VP: New General Counsel and CFO Named | GenomeWeb

NEW YORK, July 25 - Affymetrix has named Robert Ellis, who stepped down as CEO of Genometrix just before the company closed its doors June 25, to the position of vice president, product development and quality. 

The company also announced that Barbara Caulfield would be the new vice president and general counsel, replacing Vern Norviel, who has become the new general counsel of subsidiary Perlegen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.